The approval is subject to certain conditions, which the two parties have agreed to undertake following completion of the proposed transaction. The three-way transaction includes GSK buying Novartis’
The API produced is expected to provide sufficient quantities of aramchol for Galmed’s potential future Phase III clinical trials of aramchol to treat Non-Alcoholic Steato-Hepatitis (NASH). As part
MN-001 exerts its effects through several mechanisms to produce its anti-fibrotic and anti-inflammatory activity in preclinical models, including leukotriene (LT) receptor antagonism, inhibition of phosphodiesterases (PDE), and inhibition
The results showed that Jakavi improved hematocrit control without the need for phlebotomy and reduced spleen size in PV patients who had an inadequate response to or unacceptable
MGD011 is a humanized CD19 x CD3 bispecific DART protein being developed to treat B-cell hematological malignancies. As part of the deal, MacroGenics will secure a $50m upfront
The company said that ENV515 is a fully biodegradable particle replication in non-wetting templates (PRINT) particle formulation of a prostaglandin analog, travoprost, with the potential for sustained intraocular
The approval has already been given in the 28 EU member states and in the US, based on study data showing that Velphoro can control hyperphosphatemia with fewer
The risk of dementia is said to be high when the so-called anticholinergic drugs are taken in high doses over several years. Anticholinergics are a class of drug
Kyprolis is currently indicated in the US to treat patients with relapsed multiple myeloma who have received at least two other treatments. The sNDA is designed to support
Kerasal Nail is a prescription-free, over-the-counter (OTC) drug used to treat nail disease and is sold under the names Kerasal Nail, Naloc/Nalox and Emtrix. The company said that
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.